What is the definition of hospital-acquired pneumonia (HAP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition of Hospital-Acquired Pneumonia (HAP)

Hospital-acquired pneumonia (HAP) is defined as pneumonia that occurs 48 hours or more after hospital admission, which was not incubating at the time of admission. 1

Key Diagnostic Criteria

HAP is characterized by:

  • New or progressive lung infiltrates on chest radiography 1
  • Clinical evidence that the infiltrate is of infectious origin, including:
    • Fever (temperature > 38.3°C) without other cause 1
    • Leukocytosis (>12,000/mm³) or leukopenia (<4,000/mm³) 1
    • And at least two of the following:
      • Purulent sputum 1
      • Cough or dyspnea 1
      • Declining oxygenation or increased oxygen requirement 1

Subtypes of HAP

HAP can be further categorized into specific subtypes:

  • Non-ventilator HAP: Occurs after 48 hours of hospital stay in non-ventilated patients 1
  • Ventilator-associated pneumonia (VAP): Develops in ICU patients who have been mechanically ventilated for at least 48 hours 1
    • Note: Patients who require intubation after developing severe HAP do not meet the definition of VAP but should be managed similarly 1

Timing Classification

HAP can be classified based on onset relative to hospital admission:

  • Early-onset HAP: Develops within the first 5 days of hospitalization 1
  • Late-onset HAP: Develops on or after day 5 of hospitalization 1

This timing distinction is important as it affects the likely pathogens involved and guides empiric antibiotic therapy decisions.

Epidemiology and Impact

HAP is associated with significant morbidity and mortality:

  • Second most common nosocomial infection after bloodstream infections 1, 2
  • Most common infection acquired in intensive care units 1
  • Leading cause of death from nosocomial infections in critically ill patients 1, 3
  • Incidence ranges from 5 to more than 20 cases per 1000 hospital admissions 1
  • Associated with increased duration of mechanical ventilation, ICU stay, and hospital length of stay 1
  • Significantly increases healthcare costs, with estimates ranging from $10,000 to $40,000 per case 1

Common Pathogens

The microbiology of HAP varies based on timing of onset:

  • Early-onset HAP: Usually caused by community-acquired pathogens 1, 3

    • Methicillin-susceptible Staphylococcus aureus
    • Streptococcus pneumoniae
    • Haemophilus influenzae
  • Late-onset HAP: More likely to involve multidrug-resistant organisms 1, 3

    • Enterobacteriaceae
    • Pseudomonas aeruginosa
    • Acinetobacter baumannii
    • Methicillin-resistant Staphylococcus aureus

Polymicrobial infection occurs in approximately 30% of cases 1.

Diagnostic Approach

Microbiological confirmation is crucial for definitive diagnosis:

  • Based on qualitative or quantitative cultures of respiratory samples 1
  • Pathogens are identified in approximately 70% of suspected cases 1
  • Supplementary tests include blood cultures and antigen detection in urine 1

Understanding this definition and classification of HAP is essential for early recognition, appropriate diagnostic workup, and effective management to reduce associated morbidity and mortality.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hospital-acquired pneumonia: perspectives for the healthcare epidemiologist.

Infection control and hospital epidemiology, 1997

Research

Nosocomial pneumonia.

Critical care nursing quarterly, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.